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Abstract Of the six distinct isoforms of mouse protein
phosphatase 2C (PP2C) (K, L-1, L-2, L-3, L-4 and L-5), PP2CK
was specifically phosphorylated on the serine residue(s) when
expressed in COS7 cells. Analysis of phosphorylation sites using
site-directed mutagenesis demonstrated that Ser-375 and/or Ser-
377 were phosphorylated in vivo. These serine residues were the
sites of phosphorylation by casein kinase II in vitro. Phospho-
rylation of PP2CK was enhanced two-fold by the addition of
okadaic acid to the culture medium, but addition of cyclosporin A
had no such effect. These results suggest that the expressed
PP2CK is phosphorylated by a casein kinase II-like protein
kinase and dephosphorylated by PP1 and/or PP2A in COS7
cells.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
Protein phosphorylation plays a key role in the regulation
of cellular functions, and protein phosphatases in combina-
tion with protein kinases control the phosphorylation levels of
cellular proteins. The catalytic subunits of the major protein
serine/threonine phosphatases found in eukaryotic cells have
been divided into four classes, types 1, 2A, 2B and 2C (PP1,
PP2A, PP2B and PP2C, respectively) [1]. To date the presence
of ¢ve distinct PP2C genes (PP2CK, PP2CL, PP2CQ, Wip1 and
FIN13) has been reported in mammalian cells [2^6]. In addi-
tion, mouse PP2CL has been found to have ¢ve distinct iso-
forms (L-1, L-2, L-3, L-4 and L-5) which are splicing variants
originating from a single pre-mRNA [7^9]. The presence of
three isoforms of human PP2CK has also been reported [10].
Recently, information on the function of mammalian PP2C
has accumulated. PP2CK has been implicated in regulation of
the activities of AMP-activated protein kinase and Ca2/cal-
modulin-dependent protein kinase II, and both Wip1 and
FIN13 have been found to participate in regulation of cell
growth [5,6,11,12]. In this context, we have demonstrated
that expression of rat PP2CK in Saccharomyces cerevisiae cells
caused suppression of the DNA excision repair system [13]. In
the same experimental system, we also found that the ex-
pressed PP2CK was phosphorylated on serine residue(s) in
the yeast cells [14]. The phosphorylation site(s) was predicted
to be in the carboxy-terminal region of PP2CK. However,
demonstration of phosphorylation of PP2CK in mammalian
cells, determination of isoform speci¢city of the phosphoryla-
tion and identi¢cation of the phosphorylated serine residue(s)
have yet to be accomplished.
In this study, we demonstrate that of the six distinct mouse
PP2C isoforms (K, L-1, L-2, L-3, L-4 and L-5) PP2CK was
speci¢cally phosphorylated on Ser-375 and/or Ser-377 in
COS7 cells. We also provide evidence indicating that PP2CK
is dephosphorylated by PP1 and/or PP2A in the cells.
2. Materials and methods
2.1. Materials
Glutathione agarose beads, protein A agarose beads, partially hy-
drolyzed K-casein and whole histone were purchased from Sigma (St.
Louis, MO, USA). [Q-32P]ATP (3000 Ci/mmol) was obtained from
DuPont-New England Nuclear (Boston, MA, USA). Restriction en-
zymes and other modifying enzymes for DNA manipulation were
from Takara (Kyoto, Japan). Anti-hemagglutinin (HA) antibody
12CA5, biotin conjugated anti-HA and CSPD were purchased from
Boehringer Mannheim (Mannheim, Germany). Anti-mouse IgG-alka-
line phosphatase conjugate was from Promega (Madison, WI, USA).
PVDF membrane was obtained from Millipore (Bedford, MA, USA).
All other reagents were from Wako Pure Chemical (Osaka, Japan).
2.2. Strains and plasmids
Escherichia coli strain BL21 was used for the expression of GST
fusion proteins. Plasmids pEUK-C-1, pGEX-2T and pKF18k were
purchased from Clontech Laboratories (Palo Alto, CA, USA), Phar-
macia (Uppsala, Sweden) and Takara, respectively.
2.3. Construction of epitope tagged PP2C expression plasmids for
COS7 cells
Expression constructs of HA epitope (YPYDVPDYA) tagged
PP2CK (pEUK-C-HA-PP2CK) and of HA-PP2CL isoforms (pEUK-
C-HA-PP2CL-1, -2, -3, -4 and -5) were prepared essentially as de-
scribed previously [15,16].
2.4. In vitro mutagenesis
The EcoRI fragment (1.1 kbp) of mouse PP2CK cDNA [17] was
subcloned into pKF18k. The mutagenesis was performed by the oli-
gonucleotide-directed dual amber method [18] using the following
primers: 5P-TGA TTC TGC GGC AAC CGA TGA-3P (for PP2CK-
S377A), 5P-CGA CAC TGA TGC TGC GTC AAC-3P (for PP2CK-
S375A) and 5P-CGA CAC TGA TGC TGC GGC AAC CGA TGA-
3P (for PP2CK-S375A/S377A). The EcoRI fragments of pEUK-C-HA-
PP2CK and pGEX-PP2CK were replaced by the mutated EcoRI
fragments to make expression plasmids for COS7 and E. coli cells,
respectively. The ¢nal products were termed pEUK-C-HA-PP2CK-
375A (for PP2CK-S375A), pEUK-C-HA-PP2CK-377A (for PP2CK-
S377A), pEUK-C-HA-PP2CK-375A/377A (for PP2CK-S375A/
S377A), pGEX-375A (for PP2CK-S375A), pGEX-377A (for PP2CK-
S377A) and pGEX-375A/377A (for PP2CK-S375A/S377A).
2.5. Expression of recombinant PP2CK and its mutants in E. coli cells
The GST-PP2C isoforms were expressed in E. coli BL21 and puri-
¢ed using glutathione agarose beads and thrombin treatment [17].
2.6. DNA sequencing
The DNA fragments generated by PCR or in vitro mutagenesis
were examined using an ABI DNA sequencer, model 373A.
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2.7. Cell culture and transfection
The COS7 cells were grown in Dulbecco’s minimal essential me-
dium (DMEM) containing 10% (v/v) fetal calf serum, 100 units/ml
penicillin G and 100 Wg/ml streptomycin. The HA tagged PP2C
cDNAs were transiently expressed in COS7 cells using the DEAE-
dextran transfection procedure [17]. The cells were washed in ice-
cold PBS 48 h after transfection and ¢xed with 10% (w/v) trichloro-
acetic acid for 10 min at 4‡C. The ¢xed cells were collected using a cell
scraper and centrifuged at 12 000Ug for 1 min. Sodium dodecyl sul-
fate (SDS) sample bu¡er was added to the precipitate and homogen-
ized by sonication.
2.8. Phospholabeling of COS7 cells
The COS7 cells were washed with 150 mM NaCl and incubated
with phosphate-free DMEM containing [32P]orthophosphate (60 WCi/
ml) 48 h after transfection. The dish was incubated for 5 h at 37‡C
and the phospholabeled cells were harvested after washing with ice-
cold PBS. The cells were lysed using TNE bu¡er (10 mM Tris-HCl,
pH 7.5, 1% (v/v) Triton X-100, 150 mM NaCl, 1 mM EDTA and
1 mM PMSF) containing 50 mM NaF and 0.1 WM okadaic acid (OA).
After centrifugation, the anti-HA antibody 12CA5 was added to the
supernatant and the PP2C-antibody complex was recovered using
protein A agarose beads and subjected to SDS-PAGE analysis.
2.9. Phosphorylation of PP2C by casein kinase II
Casein kinase II was puri¢ed from rat liver nuclei as described by
Takeda et al. [19]. The recombinant mouse PP2CK and its point
mutants were incubated with 40 mM Tris-HCl, pH 7.5, 10 mM
MgCl2, 2 mM DTT, 0.5 mM ATP (10 WCi [Q-32P]ATP), 0.1 mg/ml
polylysine and puri¢ed casein kinase II (2 Wg) in a total volume of 25
Wl. The incorporated radioactivity was measured after SDS-PAGE
using a BAS2000 image analyzer.
2.10. Western blot analysis
Western blotting was performed by the standard procedure, using
the anti-HA antibody 12CA5 and alkaline phosphatase conjugated
anti-mouse IgG. The blots were developed by chemiluminescence us-
ing CSPD as substrate. In order to demonstrate the amount of HA-
PP2C protein precipitated by the anti-HA antibody, biotin conjugated
anti-HA antibody and streptavidin-peroxidase conjugate was used in-
stead of alkaline phosphatase conjugated anti-mouse IgG, because
HA-PP2CK protein migrated almost simultaneously with the heavy
chain of the immunoglobulin on SDS-PAGE, so that the HA-
PP2CK band was hidden by the band of the heavy chain of the IgG
when anti-mouse IgG antibody was used as the secondary antibody.
2.11. Phosphoamino acid analysis
32P-labeled PP2CK was subjected to phosphoamino acid analysis as
described by Boyle et al. [20].
2.12. Assay of protein phosphatase activity
[32P]Phosphohistone and [32P]phosphocasein were prepared by in-
cubating whole histone and partially digested K-casein, respectively,
with the catalytic subunit of protein kinase A and [Q-32P]ATP as
described previously [21,22]. The catalytic subunit of protein kinase
A was puri¢ed as described by Reimann and Beham [23]. Protein
phosphatase activity was assayed by measuring the release of
[32P]phosphate from the [32P]phosphohistone or [32P]phosphocasein,
essentially as described previously [21]. One unit of activity was de-
¢ned as the amount of enzyme which catalyzes the release of 1 nmol
phosphate per min.
3. Results
3.1. Phosphorylation of HA-PP2C isoforms expressed in COS7
cells
Cell extracts from COS7 cells transfected with expression
plasmids for six distinct mouse PP2C isoforms (K, L-1, L-2, L-
3, L-4 and L-5) were analyzed by Western blotting using the
anti-HA monoclonal antibody (12CA5). Protein bands of 46^
48 kDa were observed only when the cells were transfected
with the expression plasmids (Fig. 1A, lower panel). In order
to determine whether the HA tagged PP2C isoforms exhibited
the protein phosphatase activities characteristic of PP2C, the
activities of the immunoprecipitates were measured using
[32P]phosphohistone phosphorylated by protein kinase A as
the substrate. All the immunoprecipitates from the cell ex-
tracts that had been transfected with the expression vectors
showed substantial levels of Mg2 dependent and OA insen-
sitive histone phosphatase activity (data not shown). How-
ever, no protein phosphatase activity was detected in immu-
noprecipitates from cells transfected only with the control
vector plasmid.
In order to test whether PP2C isoforms were phosphoryl-
ated when expressed in mammalian cells, we performed
phospholabeling of COS7 cells expressing HA tagged PP2C
proteins. COS7 cells transfected with the expression plasmids
were metabolically labeled with [32P]orthophosphate and
lysed using a bu¡er containing Triton X-100. The PP2C iso-
forms were immunoprecipitated with the anti-HA antibody
and analyzed by SDS-PAGE, and the radioactivities in the
gel were visualized by autoradiography. As shown in Fig.
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Fig. 1. Phosporylation of HA tagged PP2C isoforms in COS7 cells.
A: Upper panel: COS7 cells transfected with pEUK-C-1 (lane 1),
pEUK-C-HA-PP2CK (lane 2), pEUK-C-HA-PP2CL-1 (lane 3),
pEUK-C-HA-PP2CL-2 (lane 4), pEUK-C-HA-PP2CL-3 (lane 5),
pEUK-C-PP2CL-4 (lane 6) and pEUK-C-PP2CL-5 (lane 7) were
phospholabeled by adding [32P]orthophosphate to the culture me-
dium. The cell extracts were immunoprecipitated by the anti-HA
antibody and the immunoprecipitates were subjected to SDS-PAGE.
The results of autoradiography are shown. Lower panel: Western
blot analysis was performed using the anti-HA antibody. B: The
protein band for phospho-HA-PP2CK (as shown in A) was excised
from the gel and subjected to phosphoamino acid analysis.
Fig. 2. Diagram of in vitro mutagenesis of PP2CK. The mutant ami-
no acids are underlined. The numbers indicate the positions of the
amino acid residues in mouse PP2CK.
T. Kobayashi et al./FEBS Letters 430 (1998) 222^226 223
1A, PP2CK, but no other isoform, was phosphorylated in
the cells. Phosphoamino acid analysis using high voltage
thin layer chromatography demonstrated that phosphoryl-
ation of PP2CK occurred almost exclusively on serine residues
(Fig. 1B). A trace amount of threonine phosphorylation
was observed, but no tyrosine phosphorylation could be de-
tected.
3.2. Phosphorylation of mutant PP2CK in vitro and in vivo
The putative phosphorylation sites of rat PP2CK suggested
by our previous study were in the carboxy-terminal region,
which contained two serine residues (Ser-375 and Ser-377)
[14]. The sequence of the carboxy-terminus including Ser-
375 and Ser-377 was conserved in mouse PP2CK (Fig. 2)
[17]. In order to determine the actual phosphorylation sites,
we introduced a mutation from serine to alanine at these two
serine sites by site-directed mutagenesis (Fig. 2). Fragments of
mutant PP2CK were introduced into either the pGEX-2T vec-
tor (for GST fusion) or pEUK-C vector (for COS7 expres-
sion). All three mutants were expressed as e¡ectively as wild-
type PP2CK in both E. coli (Fig. 3A, lower panel) and COS7
cells (Fig. 4A, lower panel).
The recombinant PP2CK mutant proteins were incubated
with casein kinase II and [Q-32P]ATP (Fig. 3A,B). The wild-
type mouse PP2CK was phosphorylated by casein kinase II,
con¢rming our previous observation with rat PP2CK [14]. The
stoichiometry of the phosphorylation was 1.2 mol phosphate
per mol protein. The Ser-375CAla-375 mutation (PP2CK-
S375A) caused an 87% decrease in the phosphorylation of
PP2CK (lane 4). However, the decrease in phosphorylation
produced by the Ser-377CAla-377 mutation (PP2CK-
S377A) was only 28% compared with the control (lane 3).
The mutant in which both serine residues were changed to
alanine (PP2CK-S375A/S377A) was not phosphorylated
(lane 5). These results indicate that the major phosphorylation
site for casein kinase II is Ser-375. Ser-377 was also phos-
phorylated by casein kinase II but to a much smaller extent.
Fig. 4 shows the results of the in vivo experiments. As in
the in vitro experiments, the double mutant HA-PP2CK-
S375A/S377A was not phosphorylated when expressed in
COS7 cells (lane 5), indicating that at least one of these two
serines was phosphorylated in COS7 cells. However, in con-
trast to the in vitro experiments, essentially no phosphoryla-
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Fig. 3. Phosphorylation of mutant PP2CK proteins by casein kinase
II. A: Upper panel: Wild-type and mutant PP2CK were expressed
in E. coli cells, puri¢ed by glutathione agarose beads and thrombin
treatment, and phosphorylated by casein kinase II. The results of
autoradiography after SDS-PAGE are shown. Lower panel: The gel
was stained with Coomassie brilliant blue after SDS-PAGE. B: The
radioactivities incorporated into the PP2CK proteins (A) were deter-
mined using a BAS 2000 image analyzer. Lane 1, no PP2C protein;
lane 2, PP2CK ; lane 3, PP2CK-S377A; lane 4, PP2CK-S375A; lane
5, PP2CK-S375A/S377A.
Fig. 4. Phosphorylation of mutant HA tagged PP2CK proteins in
COS7 cells. A: Upper panel: Wild-type and mutant HA-PP2CK
proteins were transiently expressed in COS7 cells and metabolically
labeled by [32P]orthophosphate. The labeled proteins were immuno-
precipitated by the anti-HA antibody and subjected to SDS-PAGE.
The radioactivities incorporated into the PP2CK proteins were vi-
sualized by autoradiography. Lower panel: Western blot analysis
was performed using the anti-HA antibody. B: The radioactivities
incorporated into the PP2CK proteins were determined using a BAS
2000 image analyzer. Lane 1, pEUK-C-1; lane 2, pEUK-C-HA-
PP2CK ; lane 3, pEUK-C-HA-PP2CK-377A; lane 4, pEUK-C-HA-
PP2CK-375A; lane 5, pEUK-C-HA-PP2CK-375A/377A.
Fig. 5. E¡ects of phosphatase inhibitors on the phosphorylation of
HA tagged PP2CK in COS7 cells. COS7 cells harboring the expres-
sion vector for HA-PP2CK were labeled by [32P]inorganic phos-
phate. OA (1 WM) or CsA (1 Wg/ml) was added to the phospholab-
eling medium 1 h before harvesting. The cells were then collected
and lysed. The HA-PP2CK proteins were immunoprecipitated from
the cell extracts by the anti-HA antibody. After SDS-PAGE of the
immunoprecipitates, the radioactivities incorporated into the PP2CK
proteins were determined using a BAS 2000 image analyzer. The re-
sults represent the means of three separate experiments þ S.D.
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tion was observed in HA-PP2CK-S377A (lane 3) while HA-
PP2CK-S375A (lane 4) was slightly phosphorylated in COS7
cells.
3.3. E¡ect of phosphatase inhibitors on the phosphorylation
of PP2CK
We next determined whether PP2CK phosphorylated in
COS7 cells was dephosphorylated by endogenous PPs. To
this end we tested the e¡ects of protein phosphatase inhibitors
on the phosphorylation of PP2CK expressed in COS7 cells.
Following incubation of the COS7 cells with
[32P]orthophosphate, 1 WM OA or 1 Wg/ml cyclosporin A
(CsA) was added to the labeling mixture and incubated for
another 1 h. The labeled PP2CK was immunoprecipitated with
the anti-HA antibody and the level of phosphorylation was
determined using a BAS 2000 image analyzer after SDS-
PAGE (Fig. 5). The phosphorylation of PP2CK was increased
two-fold by the addition of OA. However, the addition of
CsA did not a¡ect phosphorylation. These results indicated
that endogenous PPs responsible for the dephosphorylation of
PP2CK in COS7 cells were PP1 and/or PP2A.
4. Discussion
In our previous study, we have demonstrated that rat
PP2CK expressed in S. cerevisiae cells was phosphorylated
on serine residues of its carboxy-terminal region [14]. How-
ever, whether the phosphorylation was a physiological phe-
nomenon was not known since the experiments were per-
formed using a heterologous system, namely expression of
mammalian PP2C in yeast cells. In addition, the putative
phosphorylation sites of rat PP2CK were not conserved in
the S. cerevisiae PP2Cs. In this study, we demonstrated for
the ¢rst time the isoform speci¢c phosphorylation of mamma-
lian PP2C in mammalian cells, indicating that the phospho-
rylation of PP2CK is a physiologically occurring event.
Since the double mutant of PP2CK (S375A/S377A) was not
phosphorylated both in vivo and in vitro (Figs. 3 and 4), it
was suggested that PP2CK was phosphorylated by casein kin-
ase II or casein kinase II-like protein kinase in COS7 cells.
However, a marked di¡erence was observed in the phospho-
rylation level of Ser-375 between in vivo and in vitro experi-
ments when phosphorylation of a single mutant (S377A) was
examined. The reason for this discrepancy is not known. One
unique feature of the in vivo condition is that endogenous
PP(s) may a¡ect the phosphorylation of recombinant
PP2CK. It was indicated that PP1 and/or PP2A are respon-
sible for the dephosphorylation of PP2CK in COS7 cell.
Therefore, it seems reasonable to speculate that the di¡erence
in the phosphorylation level between the in vivo and in vitro
experiments was caused by a higher susceptibility of phospho-
serine-375 in the single mutant S377A to endogenous PP1
and/or PP2A than that in wild-type PP2CK. This may have
been caused by the absence of phosphoserine-377 in the mu-
tant molecule. Alternatively, phosphorylation of Ser-377 may
be a prerequisite for the phosphorylation of Ser-375 in vivo.
Peruski et al. isolated the human cDNAs encoding three
isoforms of PP2CK (K1, K2 and K3) by RT-PCR from
HL60 monocytes [10]. They reported that PP2CK1 was the
dominant isoform, comprising 75% of the PP2CK cDNAs
generated, and that the amounts of PP2CK2 and PP2CK3
were relatively low. The deduced amino acid sequences indi-
cated that the three isoforms were similar but a signi¢cant
di¡erence was observed at their carboxy-terminal regions.
Of these three human PP2CK isoforms PP2CK1 was most
homologous to rat and mouse PP2CK. Interestingly, the two
serines corresponding to Ser-375 and Ser-377 of mouse
PP2CK are conserved in human PP2CK1 and PP2CK3 but
not in PP2CK2, in which the amino-terminal side Ser is
changed to Tyr. Therefore, human PP2CK1 and PP2CK3
but not PP2CK2 may also be phosphorylated in vivo.
In our previous study, we demonstrated that the phospho-
rylation by casein kinase II did not a¡ect the enzyme activity
of PP2CK as far as arti¢cial substrates (phosphohistone or
phosphocasein) were used in the enzyme assay. However, it
still seems possible that the activity against physiological sub-
strate(s) is regulated by the phosphorylation. Alternatively,
the phosphorylation may a¡ect the binding of PP2CK to other
proteins in the cells or it may regulate the subcellular local-
ization of PP2CK. Studies to verify these hypotheses are under
way now.
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